L. Martinelli et al., DIFFERENT RESULTS OF CARDIAC TRANSPLANTATION IN PATIENTS WITH ISCHEMIC AND DILATED CARDIOMYOPATHY, European journal of cardio-thoracic surgery, 9(11), 1995, pp. 644-650
We retrospectively analyzed 275 consecutive transplanted patients, div
iding them into group A (128 patients) affected by ischemic cardiomyop
athy and group B (147 patients) affected by dilated cardiomyopathy. Th
e difference in demographic, clinical and hemodynamic preoperative and
postoperative data between the groups was studied; group A patients p
resented at transplantation with a less compromised hemodynamic pictur
e, requiring inotrope infusion and mechanical assistance less frequent
ly. The influence of etiology on early postoperative complications was
also analyzed: group A patients needed postoperative mechanical assis
tance, inotrope, infusion and prolonged mechanical ventilation more of
ten, therefore requiring a longer stay in the intensive care unit (ICU
). Hospital mortality was twice as high in group A. The older age of g
roup A patients per se did not influence these results significantly,
The long-term follow-up was then studied with particular attention to
parenchymal functions, hemodynamics, coronary artery disease, metaboli
c and surgical complications, and survival. The complication rate was
higher in group A, with more severe hypertension and higher cholestero
l levels at 1 year, a higher prevalence of accelerated coronary artery
disease (CAD) and a more frequent onset of insulin-dependent diabetes
. Surgical and vascular complications were also more frequent. The fin
al result was a better 5-year actuarial survival rate for group B pati
ents. Donor and recipient ages at the time of transplant did not influ
ence this result. We conclude that ischemic patients, even if they are
transplanted in better condition and operated more electively, have a
more critical early and long-term postoperative course and a worse su
rvival rate. These findings are not explained by advanced age, but cou
ld be due to the impact of atherosclerosis and metabolic impairments a
ssociated with ischemic disease.